Orchard Therapeutics
NasdaqGM:ORTX
$ 16,70
$0,00 (0,00%)
16,70 $
$0,00 (0,00%)
End-of-day quote: 01/24/2024

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

This stock is no longer listed on the stock exchange.

Financials

Year Year 2023 2022 2021 2020 2019 2018
EPS Earnings Per Share $-11,80 $-11,80 $-11,70 $-15,30 $-17,50 $-26,80
Earnings Earnings $-217,12M $-217,12M $-147,19M $-189,26M $-169,93M $-230,21M
RPS Revenue Per Share N/A $1,23 $0,13 $0,21 $0,26 $0,24
Revenue Revenue $22,66M $22,66M $1,68M $2,60M $2,51M $2,08M
OCF Operating Cash Flow $-75,99M $-75,99M $-125,10M $-126,27M $-166,13M $-97,54M
FCF Free Cash Flow $-85,00M $-82,50M $-127,45M $-138,96M $-170,50M $-101,57M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 66,97% 67,97% 79,67%
FCFS Free Cash Flow Per Share $0,00 $-6,45 $-10,35 $-13,97 $-18,29 $-45,02
LT Debt Long-Term Debt N/A $22,99M $32,09M $20,20M $24,70M N/A
Sha. Stocks 22,76M 18,4M 12,58M 12,37M 9,71M 8,59M
×